The Safety Profile of Sustained Release Paracetamol During Therapeutic Use and Following Overdose

Author： Dart Richard C.   Green Jody L.   Bogdan Gregory M.  

Publisher： Adis International

ISSN： 0114-5916

Source： Drug Safety, Vol.28, Iss.11, 2005-01, pp. : 1045-1056

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evaluation of a 12‐Hour Sustained‐Release Acetaminophen (Paracetamol) Formulation: A Randomized, 3‐Way Crossover Pharmacokinetic and Safety Study in Healthy Volunteers

By  

Clinical Pharmacology In Drug Development, Vol. 7, Iss. 1, 2018-01 ,pp. : 95-101

John Wiley & Sons Inc

Access to resources Recommend Favorite

Bioequivalence and Safety of Twice‐Daily Sustained‐Release Paracetamol (Acetaminophen) Compared With 3‐ and 4‐Times‐Daily Paracetamol: A Repeat‐Dose, Crossover Pharmacokinetic Study in Healthy Volunteers

By  

Clinical Pharmacology In Drug Development, Vol. 7, Iss. 1, 2018-01 ,pp. : 77-86

John Wiley & Sons Inc

Access to resources Recommend Favorite

Nabumetone: Therapeutic Use and Safety Profile in the Management of Osteoarthritis and Rheumatoid Arthritis

By Thomas Hedner  

Drugs, Vol. 64, Iss. 20, 2004-01 ,pp. : 2315-2343

Adis International

Access to resources Recommend Favorite

Nabumetone: Therapeutic Use and Safety Profile in the Management of Osteoarthritis and Rheumatoid Arthritis

By Sanford H. Roth  

Drugs, Vol. 64, Iss. 20, 2004-01 ,pp. : 2344-2345

Adis International

Access to resources Recommend Favorite

Paracetamol overdose: Hepatotoxicity following a dosing error in a child: case report

By  

Reactions Weekly, Vol. 1, Iss. 1395, 2012-01 ,pp. : 31-32

Adis International

Access to resources Recommend Favorite